RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
Clinical trial NCT06663007 · RECRUITING
Trial details
- NCT number
- NCT06663007
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-24
- Primary completion
- 2027-05-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.